Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma.
Saved in:
| Title: | Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma. |
|---|---|
| Authors: | Glen C; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom., Dobbin SJH; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom., Mangion K; Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom., Henderson A; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom., Brooksbank K; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom., Coats CJ; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom., Epstein FH; School of Engineering and Applied Science, University of Virginia, Charlottesville, Virginia, USA., Kellman P; National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA., Butler E; University of Glasgow, Glasgow, Scotland, United Kingdom., Evans TRJ; Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom., Jones R; Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom., McClure J; University of Glasgow, Glasgow, Scotland, United Kingdom., Roditi G; University of Glasgow, Glasgow, Scotland, United Kingdom., Tan YY; Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom., Waterston A; Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom., Welsh P; University of Glasgow, Glasgow, Scotland, United Kingdom., Petrie MC; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom., Lang NN; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom. Electronic address: ninian.lang@glasgow.ac.uk. |
| Source: | JACC. CardioOncology [JACC CardioOncol] 2025 Dec; Vol. 7 (7), pp. 852-866. Date of Electronic Publication: 2025 Oct 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101761697 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-0873 (Electronic) Linking ISSN: 26660873 NLM ISO Abbreviation: JACC CardioOncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41065626 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Glen+C%22">Glen C</searchLink>; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dobbin+SJH%22">Dobbin SJH</searchLink>; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Mangion+K%22">Mangion K</searchLink>; Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Henderson+A%22">Henderson A</searchLink>; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Brooksbank+K%22">Brooksbank K</searchLink>; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Coats+CJ%22">Coats CJ</searchLink>; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Epstein+FH%22">Epstein FH</searchLink>; School of Engineering and Applied Science, University of Virginia, Charlottesville, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Kellman+P%22">Kellman P</searchLink>; National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Butler+E%22">Butler E</searchLink>; University of Glasgow, Glasgow, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Evans+TRJ%22">Evans TRJ</searchLink>; Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jones+R%22">Jones R</searchLink>; Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22McClure+J%22">McClure J</searchLink>; University of Glasgow, Glasgow, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Roditi+G%22">Roditi G</searchLink>; University of Glasgow, Glasgow, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Tan+YY%22">Tan YY</searchLink>; Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Waterston+A%22">Waterston A</searchLink>; Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Welsh+P%22">Welsh P</searchLink>; University of Glasgow, Glasgow, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Petrie+MC%22">Petrie MC</searchLink>; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lang+NN%22">Lang NN</searchLink>; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, Scotland, United Kingdom. Electronic address: ninian.lang@glasgow.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101761697%22">JACC. CardioOncology</searchLink> [JACC CardioOncol] 2025 Dec; Vol. 7 (7), pp. 852-866. <i>Date of Electronic Publication: </i>2025 Oct 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101761697 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-0873 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226660873%22">26660873 </searchLink><i>NLM ISO Abbreviation: </i>JACC CardioOncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41065626 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jaccao.2025.08.006 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 852 Titles: – TitleFull: Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Glen C – PersonEntity: Name: NameFull: Dobbin SJH – PersonEntity: Name: NameFull: Mangion K – PersonEntity: Name: NameFull: Henderson A – PersonEntity: Name: NameFull: Brooksbank K – PersonEntity: Name: NameFull: Coats CJ – PersonEntity: Name: NameFull: Epstein FH – PersonEntity: Name: NameFull: Kellman P – PersonEntity: Name: NameFull: Butler E – PersonEntity: Name: NameFull: Evans TRJ – PersonEntity: Name: NameFull: Jones R – PersonEntity: Name: NameFull: McClure J – PersonEntity: Name: NameFull: Roditi G – PersonEntity: Name: NameFull: Tan YY – PersonEntity: Name: NameFull: Waterston A – PersonEntity: Name: NameFull: Welsh P – PersonEntity: Name: NameFull: Petrie MC – PersonEntity: Name: NameFull: Lang NN IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2025 Dec Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2666-0873 Numbering: – Type: volume Value: 7 – Type: issue Value: 7 Titles: – TitleFull: JACC. CardioOncology Type: main |
| ResultId | 1 |